PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- Avastin
- Generic name / active ingredient
- bevacizumab
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Intravenous infusion
- Record reviewed
- 2026-08-28
Copy from the pack in hand
Source-linked reading points
- 100 mg/4 mL and 25 mg/mL are total-content and concentration clues for the exact single-dose vial, not a number of vials, permission to save leftovers or home-infusion instructions.
- Being an anti-angiogenic or intravenous anticancer medicine does not permit self-combination, alternation or substitution with chemotherapy, another targeted medicine, immunotherapy, anticoagulation or supplements.
- With marked bleeding, sudden chest pain or breathing trouble, severe abdominal pain, an unusual wound problem, severe headache/neurologic change or another acute concern, use local urgent medical support promptly and contact the treatment team.
Reviewed presentation examples — compare every field
- Bevacizumab 100 mg/4 mL (25 mg/mL) per single-dose vial; one vial per cartonNDC 50242-060-01
- Bevacizumab 400 mg/16 mL (25 mg/mL) per single-dose vial; one vial per cartonNDC 50242-061-01